SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: S-1/A
Document Type: EX-1.1
Date Filed: 2024-07-29
Accession Number: 0001013762-24-002165
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000101376224002165/ea020832402ex1-1_synergy.htm

Chunk 12 of 15
Word Count: 1351
Character Count: 8560

Document Content:

the “Underwriting” section of the Registration Statement, the Time of Sale Disclosure Package, and the Final Prospectus only insofar as such statements relate to the amount of selling concession and re-allowance, if any, or to over-allotment, stabilization and related activities that may be undertaken by such Underwriter. Representations and Agreements to Survive Delivery. All representations, warranties, and agreements of the Company contained herein or in certificates delivered pursuant hereto, including, but not limited to, the agreements of the several Underwriters and the Company contained in Section 5(a)(vii) and Section 7 hereof, shall remain operative and in full force and effect regardless of any investigation made by or on behalf of the several Underwriters or any controlling person thereof, or the Company or any of its officers, directors, or controlling persons, and shall survive delivery of, and payment for, the Shares to and by the Underwriters hereunder. Termination of this Agreement.

The Representative shall have the right to terminate this Agreement by giving notice to the Company as hereinafter specified at any time
at or prior to the Closing Date or any Option Closing Date (as to the Option Shares to be purchased on such Option Closing Date only),
if in the discretion of the Representative, (i) there has occurred any material adverse change in the securities markets or any event,
act or occurrence that has materially disrupted, or in the opinion of the Representative, will in the future materially disrupt, the
securities markets or there shall be such a material adverse change in general financial, political or economic conditions or the effect
of international conditions on the financial markets in the United States is such as to make it, in the reasonable judgment of the Representative,
inadvisable or impracticable to market the Shares or enforce contracts for the sale of the Shares (ii) trading in the Company’s
Common Stock shall have been suspended by the Commission or the Nasdaq or trading in securities generally on the Nasdaq Stock Market,
the NYSE or the NYSE MKT shall have been suspended, (iii) minimum or maximum prices for trading shall have been fixed, or maximum ranges
for prices for securities shall have been required, on the Nasdaq Stock Market, the NYSE or NYSE MKT, by such exchange or by order of
the Commission or any other governmental authority having jurisdiction, (iv) a banking moratorium shall have been declared by federal
or state authorities, (v) there shall have occurred any attack on, outbreak or escalation of hostilities or act of terrorism involving
the United States, any declaration by the United States of a national emergency or war, any substantial change or development involving
a prospective substantial change in United States or international political, financial or economic conditions or any other calamity
or crisis, or (vi) the Company suffers any loss by strike, fire, flood, earthquake, accident or other calamity, whether or not covered
by insurance, or (vii) in the reasonable judgment of the Representative, there has been, since the time of execution of this Agreement
or since the respective dates as of which information is given in the Registration Statement, the Time of Sale Disclosure Package or
the Final Prospectus, any material adverse change in the assets, properties, condition, financial or otherwise, or in the results of
operations, business affairs or business prospects of the Company and its subsidiaries considered as a whole, whether or not arising
in the ordinary course of business. Any such termination shall be without liability of any party to any other party except that the provisions
of Section 5(a)(viii) and Section 7 hereof shall at all times be effective and shall survive such termination.

If the Representative elects to terminate this Agreement as provided in this Section, the Company and the other Underwriters shall be
notified promptly by the Representative by telephone, confirmed by letter.

Substitution of Underwriters.
If any Underwriter or Underwriters shall default in its or their obligations to purchase Shares hereunder on the Closing Date or any
Option Closing Date and the aggregate number of Shares which such defaulting Underwriter or Underwriters agreed but failed to purchase
does not exceed ten percent (10%) of the total number of Shares to be purchased by all Underwriters on such Closing Date or Option Closing
Date, the other Underwriters shall be obligated severally, in proportion to their respective commitments hereunder, to purchase the Shares
which such defaulting Underwriter or Underwriters agreed but failed to purchase on such Closing Date or Option Closing Date. If any Underwriter
or Underwriters shall so default and the aggregate number of Shares with respect to which such default or defaults occur is more than
ten percent (10%) of the total number of Shares to be purchased by all Underwriters on such Closing Date or Option Closing Date and arrangements
satisfactory to the remaining Underwriters and the Company for the purchase of such Shares by other persons are not made within forty-eight
(48) hours after such default, this Agreement shall terminate.

the remaining Underwriters or substituted Underwriters are required hereby or agree to take up all or part of the Shares of a defaulting
Underwriter or Underwriters on such Closing Date or Option Closing Date as provided in this Section 10, (i) the Company shall have the
right to postpone such Closing Date or Option Closing Date for a period of not more than five (5) full business days in order to permit
the Company to effect whatever changes in the Registration Statement, the Final Prospectus, or in any other documents or arrangements,
which may thereby be made necessary, and the Company agrees to promptly file any amendments to the Registration Statement or the Final
Prospectus which may thereby be made necessary, and (ii) the respective numbers of Shares to be purchased by the remaining Underwriters
or substituted Underwriters shall be taken as the basis of their underwriting obligation for all purposes of this Agreement. Nothing
herein contained shall relieve any defaulting Underwriter of its liability to the Company or any other Underwriter for damages occasioned
by its default hereunder. Any termination of this Agreement pursuant to this Section 10 shall be without liability on the part of any
non-defaulting Underwriters or the Company, except that the representations, warranties, covenants, indemnities, agreements and other
statements set forth in Section 2 and 3, the obligations with respect to expenses to be paid or reimbursed pursuant to Section 5 and
the provisions of Section 5(a)(viii) and Section 8 and Sections 10 through 18, inclusive, shall not terminate and shall remain in full
force and effect.

used in this Agreement, the term “Underwriter” shall be deemed to include any person substituted for a defaulting Underwriter
under this Section 10. Any action taken under this Section 10 shall not relieve any defaulting Underwriter from liability in respect
of any default of such Underwriter under this Agreement.

Notices. Except as otherwise
provided herein, all communications hereunder shall be in writing and, if to the Representative, shall be mailed, delivered or telecopied
to Roth Capital Partners, LLC, 800 San Clemente Drive, Suite 400, Newport Beach, CA 92660, telecopy number: (949) 720-7227, Attention:
Managing Director; and if to the Company, shall be mailed, delivered or telecopied to it at ____________________________, telecopy number:
_____________, Attention: ________________; or in each case to such other address as the person to be notified may have requested in
writing. Any party to this Agreement may change such address for notices by sending to the parties to this Agreement written notice of
a new address for such purpose.

Persons Entitled to Benefit of Agreement.
This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective successors and assigns and the
controlling persons, officers and directors referred to in Section 7. Nothing in this Agreement is intended or shall be construed to
give to any other person, firm or corporation any legal or equitable remedy or claim under or in respect of this Agreement or any provision
herein contained. The term “successors and assigns” as herein used shall not include any purchaser, as such purchaser, of
any of the Shares from any Underwriters.